Developing probiotics as food and drugs: scientific and regulatory challenges
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago, IL
Univ. of Chicago Press
2008
|
| Schriftenreihe: | Clinical infectious diseases
Supplement ; 46,2 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | S. 53 - 151 Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV023169432 | ||
| 003 | DE-604 | ||
| 005 | 20080219 | ||
| 007 | t | ||
| 008 | 080218s2008 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)245550675 | ||
| 035 | |a (DE-599)BVBBV023169432 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 245 | 1 | 0 | |a Developing probiotics as food and drugs |b scientific and regulatory challenges |c guest ed.: Patricia L. Hibberd ... |
| 264 | 1 | |a Chicago, IL |b Univ. of Chicago Press |c 2008 | |
| 300 | |a S. 53 - 151 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Clinical infectious diseases : Supplement |v 46,2 | |
| 650 | 4 | |a Food Microbiology | |
| 650 | 4 | |a Health Food | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Probiotics |x Nutritional aspects |v Congresses | |
| 650 | 4 | |a Probiotics |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Probiotics |x therapeutic use | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Hibberd, Patricia L. |e Sonstige |4 oth | |
| 830 | 0 | |a Clinical infectious diseases |v Supplement ; 46,2 |w (DE-604)BV004765736 |9 46,2 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016356117&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016356117 | ||
Datensatz im Suchindex
| _version_ | 1804137430827139073 |
|---|---|
| adam_text | Clinical Infectioi
DEVELOPING PROBIOTI
Scientific and Re
S53 Executive Summary: Scientific and Regulatory
Challenges of Development of Probiotics
as Foods and Drugs
Freddie Ann Hoffman, James T. Heimbach, Mary Ellen Sanders,
and Patricia L Hibberd
S58 Probiotics: Definition, Sources, Selection,
and Uses
Mary Ellen Sanders
S62 How Science Will Help Shape Future Clinical
Applications of Probiotics
Gregor Reid
S67 Probiotics in the United States
Jon A. Vanderhoof and Rosemary Young
S73 Current Marketplace for Probiotics: A Japanese
Perspective
Harunobu Amagase
S76 Probiotic Formulations and Applications,
the Current Probiotics Market, and Changes
in the Marketplace: A European Perspective
Maija Saxelin
S80 Impact of the Intestinal Microbiota
on the Development of Mucosal Defense
H. Rex Gaskins, Jennifer A. Croix, Noriko Nakamura,
and Gerardo M. Nava
S87 Mechanisms of Action of Probiotics
W. Allan Walker
S92 Preclinical Testing in the Development
of Probiotics: A Regulatory Perspective
with Bacillus Strains as an Example
Iryna Sorokulova
S96 Clinical Indications for Probiotics: An Overview
B. R. Goldin and S. L Gorbach
S101 Clinical Research on Probiotics: The Interface
between Science and Regulation
Carmen Tamayo
# 1 February 2008
L4-O J— -LoCdoCo Supplement 2
ICS AS FOOD AND DRUGS
gulatory Challenges
SI04 The Safety of Probiotics
David R. Snydman
SI 12 Environmental Assessment Requirements for Live
Biological Drugs
Ann Sutton
SI 15 Regulation of Probiotic Substances as Ingredients
in Foods: Premarket Approval or Generally
Recognized as Safe Notification
Antonia Mattia and Robert Merker
SI 19 US Food and Drug Administration Regulations
Governing Label Claims for Food Products,
Including Probiotics
Leila G. Saldanha
S122 Health-Benefit Claims for Probiotic Products
James T. Heimbach
SI25 Development of Probiotics as Biologic Drugs
Freddie Ann Hoffman
SI28 Product Development of Probiotics as Biological
Drugs
Ann Sutton
S133 The US Food and Drug Administration
and Probiotics: Regulatory Categorization
Frederick H. Degnan
S137 Probiotic Foods and Drugs: Impact of US
Regulatory Status on Design of Clinical Trials
Patricia L. Hibberd and Lisa Davidson
S141 Business Considerations in the Development
of Probiotics
Freddie Ann Hoffman
S144 Role of Probiotics Stakeholders in Future
Research and Policy on Probiotics Use
in the United States
Marguerite Klein and Johanna Dwyer
|
| adam_txt |
Clinical Infectioi
DEVELOPING PROBIOTI
Scientific and Re
S53 Executive Summary: Scientific and Regulatory
Challenges of Development of Probiotics
as Foods and Drugs
Freddie Ann Hoffman, James T. Heimbach, Mary Ellen Sanders,
and Patricia L Hibberd
S58 Probiotics: Definition, Sources, Selection,
and Uses
Mary Ellen Sanders
S62 How Science Will Help Shape Future Clinical
Applications of Probiotics
Gregor Reid
S67 Probiotics in the United States
Jon A. Vanderhoof and Rosemary Young
S73 Current Marketplace for Probiotics: A Japanese
Perspective
Harunobu Amagase
S76 Probiotic Formulations and Applications,
the Current Probiotics Market, and Changes
in the Marketplace: A European Perspective
Maija Saxelin
S80 Impact of the Intestinal Microbiota
on the Development of Mucosal Defense
H. Rex Gaskins, Jennifer A. Croix, Noriko Nakamura,
and Gerardo M. Nava
S87 Mechanisms of Action of Probiotics
W. Allan Walker
S92 Preclinical Testing in the Development
of Probiotics: A Regulatory Perspective
with Bacillus Strains as an Example
Iryna Sorokulova
S96 Clinical Indications for Probiotics: An Overview
B. R. Goldin and S. L Gorbach
S101 Clinical Research on Probiotics: The Interface
between Science and Regulation
Carmen Tamayo
# 1 February 2008
L4-O J—''-LoCdoCo Supplement 2
ICS AS FOOD AND DRUGS
gulatory Challenges
SI04 The Safety of Probiotics
David R. Snydman
SI 12 Environmental Assessment Requirements for Live
Biological Drugs
Ann Sutton
SI 15 Regulation of Probiotic Substances as Ingredients
in Foods: Premarket Approval or "Generally
Recognized as Safe" Notification
Antonia Mattia and Robert Merker
SI 19 US Food and Drug Administration Regulations
Governing Label Claims for Food Products,
Including Probiotics
Leila G. Saldanha
S122 Health-Benefit Claims for Probiotic Products
James T. Heimbach
SI25 Development of Probiotics as Biologic Drugs
Freddie Ann Hoffman
SI28 Product Development of Probiotics as Biological
Drugs
Ann Sutton
S133 The US Food and Drug Administration
and Probiotics: Regulatory Categorization
Frederick H. Degnan
S137 Probiotic Foods and Drugs: Impact of US
Regulatory Status on Design of Clinical Trials
Patricia L. Hibberd and Lisa Davidson
S141 Business Considerations in the Development
of Probiotics
Freddie Ann Hoffman
S144 Role of Probiotics Stakeholders in Future
Research and Policy on Probiotics Use
in the United States
Marguerite Klein and Johanna Dwyer |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV023169432 |
| ctrlnum | (OCoLC)245550675 (DE-599)BVBBV023169432 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01466nam a2200361 cb4500</leader><controlfield tag="001">BV023169432</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080219 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080218s2008 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)245550675</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023169432</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Developing probiotics as food and drugs</subfield><subfield code="b">scientific and regulatory challenges</subfield><subfield code="c">guest ed.: Patricia L. Hibberd ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, IL</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 53 - 151</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Clinical infectious diseases : Supplement</subfield><subfield code="v">46,2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Food Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Food</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Humans</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Probiotics</subfield><subfield code="x">Nutritional aspects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Probiotics</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Probiotics</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hibberd, Patricia L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Clinical infectious diseases</subfield><subfield code="v">Supplement ; 46,2</subfield><subfield code="w">(DE-604)BV004765736</subfield><subfield code="9">46,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016356117&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016356117</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV023169432 |
| illustrated | Illustrated |
| index_date | 2024-07-02T19:56:59Z |
| indexdate | 2024-07-09T21:12:10Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016356117 |
| oclc_num | 245550675 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | S. 53 - 151 Ill., graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Univ. of Chicago Press |
| record_format | marc |
| series | Clinical infectious diseases |
| series2 | Clinical infectious diseases : Supplement |
| spelling | Developing probiotics as food and drugs scientific and regulatory challenges guest ed.: Patricia L. Hibberd ... Chicago, IL Univ. of Chicago Press 2008 S. 53 - 151 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Clinical infectious diseases : Supplement 46,2 Food Microbiology Health Food Humans Probiotics Nutritional aspects Congresses Probiotics Therapeutic use Congresses Probiotics therapeutic use (DE-588)1071861417 Konferenzschrift gnd-content Hibberd, Patricia L. Sonstige oth Clinical infectious diseases Supplement ; 46,2 (DE-604)BV004765736 46,2 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016356117&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Developing probiotics as food and drugs scientific and regulatory challenges Clinical infectious diseases Food Microbiology Health Food Humans Probiotics Nutritional aspects Congresses Probiotics Therapeutic use Congresses Probiotics therapeutic use |
| subject_GND | (DE-588)1071861417 |
| title | Developing probiotics as food and drugs scientific and regulatory challenges |
| title_auth | Developing probiotics as food and drugs scientific and regulatory challenges |
| title_exact_search | Developing probiotics as food and drugs scientific and regulatory challenges |
| title_exact_search_txtP | Developing probiotics as food and drugs scientific and regulatory challenges |
| title_full | Developing probiotics as food and drugs scientific and regulatory challenges guest ed.: Patricia L. Hibberd ... |
| title_fullStr | Developing probiotics as food and drugs scientific and regulatory challenges guest ed.: Patricia L. Hibberd ... |
| title_full_unstemmed | Developing probiotics as food and drugs scientific and regulatory challenges guest ed.: Patricia L. Hibberd ... |
| title_short | Developing probiotics as food and drugs |
| title_sort | developing probiotics as food and drugs scientific and regulatory challenges |
| title_sub | scientific and regulatory challenges |
| topic | Food Microbiology Health Food Humans Probiotics Nutritional aspects Congresses Probiotics Therapeutic use Congresses Probiotics therapeutic use |
| topic_facet | Food Microbiology Health Food Humans Probiotics Nutritional aspects Congresses Probiotics Therapeutic use Congresses Probiotics therapeutic use Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016356117&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004765736 |
| work_keys_str_mv | AT hibberdpatricial developingprobioticsasfoodanddrugsscientificandregulatorychallenges |